Clinical analytics and biostatistics services for pharma and biotech R&D
Ephicacy delivers data analytics and clinical programming services to life-sciences companies, with roots in biostatistics and regulatory-grade data management (CDISC SDTM, ADaM). The tech stack—SAS, R, Medidata Rave—mirrors the compliance-heavy workflows of clinical trials. Current project velocity signals internal scaling pressure: they're standardizing a global R codebase, automating data-management pipelines, and tightening programming standards, while simultaneously pushing external marketing for biometrics services. Hiring is accelerating across data and research roles, mostly at senior and lead level.
Ephicacy was founded in 2005 in Iselin, NJ, and expanded to Bangalore, India in 2009 to establish a global delivery center. The company serves pharmaceutical, biotech, and healthcare organizations worldwide with three core service lines: biostatistical analysis, clinical data management (including SDTM and ADaM compliance), and healthcare analytics technology. The delivery model blends US-based client engagement with India-based project execution. Ephicacy is ISO 9001:2015 and ISO 27001:2013 certified, reflecting the regulatory rigor required in clinical trial support. The team comprises biostatisticians, clinical programmers, data managers, and domain specialists.
SAS, R (with tidyverse, dplyr, ggplot2), R Markdown, Medidata Rave, and CDISC standards (SDTM and ADaM). GitHub is used for version control across the codebase.
Global R codebase standardization, CDM (clinical data management) automation, programming standards improvements, and external marketing for biometrics and NCA services. Internal focus includes PK merge files and NONMEM analysis workflows.
Other companies in the same industry, closest in size